Targeted drug delivery system for oral cancer therapy using sonoporation

Journal of Oral Pathology and Medicine

Volumn 38, Issue 7, 2009, Pages 572-579

  Maeda, Hironobu ^a,b   Tominaga, Kazuhiro ^b   Iwanaga, Kenjiro ^b   Nagao, Fuminori ^b   Habu, Manabu ^b   Tsujisawa, Toshiyuki ^a   Seta, Yuji ^c   Toyoshima, Kuniaki ^c   Fukuda, Jin Ichi ^b   Nishihara, Tatsuji ^a,d  

^a Department of Health Promotion   (Japan)

^b Department of Oral and Maxillofacial Surgery

^c KYUSHU DENTAL COLLEGE   (Japan)

^d NONE   (Japan)

Author keywords

Anti epidermal growth factor receptor antibody; Apoptosis; Sonoporation; Squamous cell carcinoma

Indexed keywords

ANTIBODY; BLEOMYCIN; EPIDERMAL GROWTH FACTOR RECEPTOR;

APOPTOSIS; ARTICLE; BINDING AFFINITY; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL GROWTH; CELL SURFACE; CELL TRANSFORMATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; GENE THERAPY; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; LOW DRUG DOSE; MOUTH CANCER; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SONOPORATION; SQUAMOUS CELL CARCINOMA; ULTRASOUND;

EID: 70350306662     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2009.00759.x     Document Type: Article

References (24)

1. Tachibana K, Uchida T, Ogawa K, Yamashita N, Tamura K. Induction of cell-membrane porosity by ultrasound. Lancet 1999; 353: 1409.
2. Kishida T, Asada H, Itokawa Y, et al. Electrochemo-gene therapy of cancer: intratumoral delivery of interleukin-12 gene and bleomycin synergistically induced therapeutic immunity and suppressed subcutaneous and metastatic melanomas in mice. Mol Ther 2003; 8: 738-745
3. Gothelf A, Mir LM, Gehl J. Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation. Cancer Treat Rev 2003; 29: 371-387
4. Iwanaga K, Tominaga K, Maeda H, et al. Local delivery system of cytotoxic agents to tumors by focused sonoporation. Cancer Gene Ther 2007; 14: 354-363
5. Wang Z, Sengupta R, Banerjee S, et al. Epidermal growth factor receptor-related protein inhibits cell growth and invasion in pancreatic cancer. Cancer Res 2006; 66: 7653-7660
6. Kurai J, Chikumi H, Hashimoto K, et al. Antibodydependent cellular cyototoxity mediated by cetuximab against lung cancer cell lines. Clin Cancer Res 2007; 13: 1552-1561
7. Kamata N, Chida K, Rikimaru K, Horikoshi M, Enomoto S, Kuroki T. Growth-inhibitory effects of epidermal growth factor and overexpression of its receptors on human squamous cell carcinomas in culture. Cancer Res 1986; 46: 1648-1653
8. Adelsman MA, McCarthy JB, Shimizu Y. Stimulation of b1-integrin function by epidermal growth factor and heregulin-b has distinct requirements for erbB2 but a similar dependence on phosphoinositide 3-OH kinase. Mol Biol Cell 1999; 10: 2861-2878
9. Nie F, Xu H, Tang Q, Lu M. Microbubble-enhanced ultrasound exposure improves gene transfer in vascular endothelial cells. World J Gastroenterol 2006; 12: 7508-7513
10. Ogawa K, Tachibana K, Uchida T, et al. High-resolution scanning electron microscopic evaluation of cell-membrane porosity by ultrasound. Med Electron Microsc 2001; 34: 249-253
11. Tachibana K, Tachibana S. Application of ultrasound energy as a new drug delivery system. Jpn J Appl Phys 1999; 38: 3014-3019
12. Shafer WG, Hine MK, Levy BM. A textbook of oral pathology, 4th edn. Philadelphia: WB Saunders, 1983; 112-127
13. Mir LM. Therapeutic perspectives of in vivo cell electropermeabilization. Bioelectrochemistry 2001; 53: 1-10.
14. Roy SN, Horwitz SB. Characterization of the association of radiolabeled bleomycin A2 with HeLa cells. Cancer Res 1984; 44: 1541-1546
15. Arteaga CL. The epidermal growth factor receptor: from mutant oncogene in nonhuman cancers to therapeutic target in human neoplasia. J Clin Oncol 2001; 15: 32-40.
16. Lee EJ, Kim J, Lee SA, et al. Characterization of newly established oral cancer cell lines derived from six squamous cell carcinoma and two mucoepidermoid carcinoma cells. Exp Mol Med 2005; 5: 379-390
17. Cohenuram M, Wasif Saif M. Epidermal growth factor receptor inhibition strategies in pancreatic cancer: past, present and the future. J Pancreas 2007; 8: 4-15.
18. Yang JL, Qu XJ, Russell PJ, Goldstein D. Regulation of epidermal growth factor receptor in human colon cancer cell line by interferon α. Gut 2004; 53: 123-129
19. Lammerts van Bueren JJ, Bleeker WK, Parren PWHI, et al. Effect of target dynamics on pharmacokinetics of a novel therapeutic antibody against the epidermal growth factor receptor: implications for the mechanisms of action. Cancer Res 2006; 66: 7630-7638
20. Tabata Y. Therapeutic trials based on combination of drug delivery system and ultrasound. In: ter Haar GR, Rivens I, eds. Fourth international symposium on therapeutic ultrasound. New York: American Institute of Physics, 2005; 77-80.
21. Miyoshi N, Sostric JZ, Riesz P. Correlation between sonochemistry of surfactants and human leukaemia cell killing by ultrasound and porphyrins. In: ter Haar GR, Rivens I, eds. Fourth international symposium on therapeutic ultrasound. New York: American Institute of Physics, 2005; 84-87.
22. Wu J. Delivery of DNA and antibodies into cells using sonoporation and electroporation. In: ter Haar GR, Rivens I, eds. Fourth international symposium on therapeutic ultrasound. New York: American Institute of Physics, 2005; 94-99
23. Liang HD, Lu QL, Xue SA, Halliwell M, Kodama T, et al. Optimisation of ultrasound-mediated gene transfer (sonoporation) in skeletal muscle cells. Ultrasound Med Biol 2004; 30: 1523-1529
24. Bull JL. The application of microbubbles for targeted drug delivery. Expert Opin Drug Deliv 2007; 4: 475-493